Ford Robert B

Average Profitability
25.56%
Insider Buys Quantity
1
Insider Buys Sum
$998,690.70
Insider Sells Quantity
4
Insider Sells Sum
$37.91M

Insider Activity of Ford Robert B

According to the SEC Form 4 filings, Ford Robert B, being in a position of

  1. CHAIRMAN AND CEO at Abbott Laboratories,
    оver the last 12 months, has bought 0 shares, and sold 141679 shares for $16.49M,
    over all time since 2016-02-29, has bought 25550 shares for $998,691, and sold 414450 shares for $37.91M.

The largest purchase of all time was on 2016-12-14 and amounted to 25550 shares of Abbott Laboratories for $998,691.

The largest sale of all time was on 2024-09-12 and amounted to 141679 shares of Abbott Laboratories for $16.49M.

Biography of Ford Robert B

Ford Robert B, commonly known as Robert Ford, is a pivotal figure in the healthcare and medical devices industry, serving as the President and CEO of Abbott Laboratories—a global healthcare leader. Born on July 1, 1973, Ford has been instrumental in shaping Abbott’s strategic direction and innovation. Ford earned his bachelor’s degree in Electrical Engineering from Boston University and later complemented his technical skills with an MBA from UC Berkeley's Haas School of Business, equipping him with a robust foundation in both engineering and …

2024-09-12SaleAbbott Laboratories
ABT
CHAIRMAN AND CEO
141,679
0.0081%
$116.41$16.49M-0.8%
2022-08-25SaleAbbott Laboratories
ABT
CHAIRMAN AND CEO
102,425
0.0081%
$105.10$10.77M+0.6%
2018-01-30SaleAbbott Laboratories
ABT
Executive Vice President
166,934
0.0096%
$63.01$10.52M+4.39%
2016-12-14PurchaseAbbott Laboratories
ABT
Executive Vice President
25,550
0.0017%
$39.09$998,691+25.56%
2016-02-29SaleAbbott Laboratories
ABT
Executive Vice President
3,412
0.0002%
$39.28$134,040+6.86%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.